All lobbying filings

CHAMBER HILL STRATEGIES

Lobbying for OS THERAPIES · biotechnology company

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 6, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New York

Official filing document

Lobbyists on this filing 3

JENNIFER BELL

Previously held: Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD)
SHAWN FRIESEN

Previously held: Legislative Director, Rep. Mac Collins (R-GA)); Legislative Assistant, Rep. Tom Ewing (IL-15); Clerk, House Judiciary Committee
JENNIFER HOLLAND

Previously held: Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Pharmacy

cancer immunotherapy and antibody treatment; osteosarcoma

Health Issues

cancer immunotherapy and antibody treatment; osteosarcoma

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.